Literature DB >> 11003214

Alcohol inhibits the progression as well as the initiation of atherosclerotic lesions in C57Bl/6 hyperlipidemic mice.

E E Emeson1, V Manaves, B S Emeson, L Chen, I Jovanovic.   

Abstract

BACKGROUND: Evidence that a moderate consumption of alcohol is associated with a reduced incidence of and mortality due to coronary artery disease continues to accumulate. Despite recent evidence that substances in red wine confer resistance to coronary artery disease, it is clear that at least a substantial proportion of the protective effect is due to the alcohol content of the beverage. We have previously shown that the chronic ingestion of alcohol incorporated into a total liquid diet during a 24-week period inhibits the development of fatty streak lesions in hyperlipidemic C57Bl/6 mice. We have now repeated this study and demonstrated that alcohol continues to markedly inhibit atherogenesis during a 48-week period.
METHODS: Mice were fed a high fat atherogenic liquid diet with 0% or 6% alcohol or a high fat atherogenic pelleted diet with 0% or 15% alcohol in their drinking water. After 24 and 48 weeks on these diets, subgroups of mice were euthanized and the aortas were studied for extent of atherosclerosis. Plasma lipid levels were also measured and flow cytometry studies performed to characterize their T and B lymphocyte populations. Additional groups of mice were given the high fat atherogenic diets for 24 weeks to allow lesions to develop and were then treated with alcohol diets to determine whether they inhibit the progression of the lesions.
RESULTS: The alcohol diets suppressed the development of atherosclerotic lesions at both 24 and 48 weeks in both the liquid and pelleted diet models. The addition of the alcohol diets after allowing lesions to form for 24 weeks halted the further progression of the lesions. The alcohol treatments also decreased the plasma levels of total cholesterol and high density lipoprotein (HDL) cholesterol at almost all time intervals.
CONCLUSIONS: We conclude that alcohol not only inhibits the initial development of atherosclerotic lesions but also inhibits the progression of existing atherosclerotic lesions. The alcohol-mediated decrease in HDL cholesterol in these experiments suggests that HDL plays little or no role in amelioration of atherogenesis in this model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003214

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

1.  Alcohol inhibits smooth muscle cell proliferation via regulation of the Notch signaling pathway.

Authors:  David Morrow; John P Cullen; Weimin Liu; Paul A Cahill; Eileen M Redmond
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-07       Impact factor: 8.311

2.  Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells.

Authors:  Katherine A Radek; Elizabeth J Kovacs; Richard L Gallo; Luisa A DiPietro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-09       Impact factor: 4.733

3.  Moderate dose alcohol protects against serum amyloid protein A1-induced endothelial dysfunction via both notch-dependent and notch-independent pathways.

Authors:  Naresh K Rajendran; Weimin Liu; Charles C Chu; Paul A Cahill; Eileen M Redmond
Journal:  Alcohol Clin Exp Res       Date:  2021-09-29       Impact factor: 3.455

Review 4.  Alcohol and cardiovascular disease--modulation of vascular cell function.

Authors:  Paul A Cahill; Eileen M Redmond
Journal:  Nutrients       Date:  2012-04-19       Impact factor: 5.717

5.  Early vascular damage from smoking and alcohol in teenage years: the ALSPAC study.

Authors:  Marietta Charakida; George Georgiopoulos; Frida Dangardt; Scott T Chiesa; Alun D Hughes; Alicja Rapala; George Davey Smith; Debbie Lawlor; Nicholas Finer; John E Deanfield
Journal:  Eur Heart J       Date:  2019-01-21       Impact factor: 29.983

6.  Prevalence and Risk Factors of Carotid Plaque Among Middle-aged and Elderly Adults in Rural Tianjin, China.

Authors:  Changqing Zhan; Min Shi; Ying Yang; Hongbo Pang; Shizao Fei; Lingling Bai; Bin Liu; Jun Tu; Yong Huo; Xianjia Ning; Yan Zhang; Jinghua Wang
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.